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Development and validation 
of a clinical prediction model 
for patient-reported pain and 
function after primary total knee 
replacement surgery
M. T. Sanchez-Santos1,3, C. Garriga  1, A. Judge1,2, R. N. Batra1, A. J. Price1, A. D. Liddle1,  
M. K. Javaid1,2, C. Cooper1,2, D. W. Murray1 & N. K. Arden  1,2
To develop and validate a clinical prediction model of patient-reported pain and function after 
undergoing total knee replacement (TKR). We used data of 1,649 patients from the Knee Arthroplasty 
Trial who received primary TKR across 34 centres in the UK. The external validation included 595 
patients from Southampton University Hospital, and Nuffield Orthopaedic Centre (Oxford). The 
outcome was the Oxford Knee Score (OKS) 12-month after TKR. Pre-operative predictors including 
patient characteristics and clinical factors were considered. Bootstrap backward linear regression 
analysis was used. Low pre-operative OKS, living in poor areas, high body mass index, and patient-
reported anxiety or depression were associated with worse outcome. The clinical factors associated 
with worse outcome were worse pre-operative physical status, presence of other conditions affecting 
mobility and previous knee arthroscopy. Presence of fixed flexion deformity and an absent or damaged 
pre-operative anterior cruciate ligament (compared with intact) were associated with better outcome. 
Discrimination and calibration statistics were satisfactory. External validation predicted 21.1% of the 
variance of outcome. This is the first clinical prediction model for predicting self-reported pain and 
function 12 months after TKR to be externally validated. It will help to inform to patients regarding 
expectations of the outcome after knee replacement surgery.
Total knee replacement (TKR) surgery is a common procedure with 86,438 performed in 2014 in England, Wales, 
Northern Ireland and the Isle of Man1; and 7,169 primary knee arthroplasties performed in 2013 in Scotland2. It 
is one of the most effective surgical interventions, where patients experience substantial improvements in mental 
health, satisfaction and functional status in addition to a decrease in pain, and these effects are maintained over 
the long term3. However, up to 20% of patients are not satisfied with their outcome4–6.
Patient-reported outcome measures (PROMs) are typically recorded before and after surgery for TKR, using 
tools such as the Oxford Knee Score (OKS) which measures pain and functional status7. Pain and functional 
status after knee surgery depends on a wide range of factors, such as age8,9, gender10,11, socioeconomic status12,13, 
social support14, mental health14,15, pain and function before the surgery16, number of comorbidities17, and also 
implant and hospital type18. Although these studies provide information on different risk factors, they have been 
unable to explain much of the variability in outcome following surgery.
In clinical medicine, a multivariable prediction model combines information from multiple predictors to 
predict the probability of or risk for a specific disease or outcome19, with the purpose of informing patients and 
guiding clinicians in decision-making on further health service strategies.
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Therefore, as an example application of clinical prediction model, we developed and externally validated a 
simple prediction model for improvement in pain and function 12 months after TKR using data from the Knee 
Arthroplasty Trial (KAT)20,21 (development dataset) and the Clinical Outcomes in Arthroplasty study (COASt) 
(validation dataset).
Results
Descriptive statistics. In the development cohort (KAT), we analysed information on 1,649 patients who 
agreed to complete both pre- and post-operative OKS questionnaires. We used information on 595 patients in 
the validated cohort (COASt). Patient characteristics from derivation and validation studies (case mix) are shown 
in Table 1. Broadly, patient’s characteristics were generally similar in the development and the validation studies. 
Compared with the COASt study, patients in the KAT study were more likely to present anxiety or depression and 
damaged pre-operative anterior cruciate ligament (ACL), they also had lower ASA grading system and were less 
likely to have other condition affecting mobility and pre-operative fixed flexion deformity.
Distribution of outcome and potential predictors in responders and non-responders in the development and 
the validation cohorts are presented in Supplementary Table S1. Responders in the KAT tended to have better 
pre-operative OKS, better physical status, and less anxiety or depression scores than non-responders. Responders 
in the COASt study were less often singles, had less anxiety or depression and were less likely to present general 
disease (see Supplementary Table S1).
Missing data. Missing values for all variables included in the analysis are given in Supplementary Table S2. For 
the majority of factors in the development and the validation datasets the proportion of missing data was ≤20%. 
However, missingness was higher for socioeconomic status in the KAT dataset and for disease side, fixed flexion 
deformity and pre-operative ACL in the COASt dataset.
Predictors of Outcome – model development. Of the 14 variables entered into a backward regression 
model, ten variables were identified as predictors of post-operative OKS in the KAT study. Regression coefficients 
and 95% confidence intervals (CI) for each predictor are shown in Table 2. A positive regression coefficient value 
indicates that the group had better post-operative pain/function and a negative value indicates that the group had 
worse post-operative pain/function.
Worse pre-operative OKS, self-reported anxiety/depression, presence of ASA grade 3/4 (compared to fit and 
healthy), presence of other conditions affecting mobility and previous knee arthroscopy were strongly associated 
with worse outcome. Increasing deprivation score and increasing BMI were associated with decreasing OKS at 
12 months follow-up (worse pain/function). Presence of fixed flexion deformity and damaged/absent ACL (com-
pared with intact) were significantly associated with better outcome at 12 months after TKR.
A significant interaction between age and gender was found (P-value < 0.001) and included into the final 
model. Patients aged younger than 60 and older than 80 presented a worse pain and functional status at 12 
months after knee surgery, and this effect also varied by gender. Younger women (age < 60) had better outcome 
than men; but in the oldest age group (age 80 or more) women had worse outcomes than men. There was no dif-
ference of gender on OKS outcome in the middle age groups (age 60 to 80).
Internal validation. The bias-corrected R2 statistic in the final predictive model including the patient and 
clinical factors was 17.6%. Age, sex and pre-operative OKS explained 12.8% of the variability in outcome, when 
the other patients’ characteristics were included 14.7% of the variance of outcome was explained, reaching 17.6% 
when clinical variables were added. Model calibration was good, with close agreement between predicted and 
observed values of post-operative OKS at 12 months after TKR (Fig. 1).
External validation. The model showed better discriminatory ability than the model internally validated 
with an adjusted R2 of 21.1%. Calibration shows underestimation of the predicted values with regard to the 
observed data in COASt but with close agreement between both scores (Fig. 1).
Discussion
We have developed and externally validated a new prediction model for patient-reported pain and function after 
TKR by using patient characteristics and clinical variables that are easy to measure. To our knowledge, this is the 
first study to attempt external validation for predicting outcome after TKR. The model showed adequate pre-
dictive validity with an R2 of 17.5% and had good calibration across all deciles of predicted 12-month OKS. The 
external validation improved prediction up to 21.1% but this prediction underestimated observed OKS.
Presence of a fixed flexion deformity, and an absent or damaged pre-operative ACL (compared with intact 
ACL) were all significantly associated with better outcome.
Determinants of worse outcome included in the final model were: worse pre-operative OKS, living in poor 
areas, high BMI, worse mental health, worse ASA grade, presence of other condition affecting mobility and knee 
arthroscopy.
All predictors have undergone internal validation using bootstrap techniques to ensure they were consistently 
identified as significant predictors.
This prediction model provides an individualised estimate of post-operative OKS, and change in OKS, and 
this information will help to inform to patients regarding expectations of the outcome after knee replacement 
surgery.
Few papers have described clinical risk prediction models for outcomes of knee arthroplasty13,22–24, how-
ever these studies are informative for decision-making but require confirmation and external validation in new 
patients cohorts.
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We included known risk factors in our model and report coefficients similar in both magnitude and direction 
to those reported elsewhere for outcome after replacement. Within our study, we found that worse pre-operative 
knee pain and function score and greater socioeconomic deprivation, based on residential area, were significantly 
associated with worse patient reported outcomes, and these associations have been well documented12–14,16,25,26. 
We also found that patients with self-reported anxiety/depression were most likely to have worse post-operative 
OKS. These results have been consistent with previous reports, using measures of mental health such as the 
SF-3627 and the EQ-5D-3L13. Within this study higher BMI was associated with worse post-operative OKS. There 
is controversy with respect to BMI, previous studies found association between high BMI and worse outcome28,29 
whereas others found no evidence of an association13,30. A possible explanation for this association may be that 
Variable
KAT (1649) COASt (n = 595)
n n
OKS at follow-up (units, median, IQR) 1,649 36 (27–42) 595 39 (30–44)
Age at operation (years, %)
    <60 168 (10.2) 65 (10.9)
    60–69 613 (37.2) 206 (34.6)
    70–79 691 (41.9) 246 (41.3)
    80 or more 177 (10.7) 78 (13.1)
Gender (%)
    Male 728 (44.2) 256 (43.0)
    Female 921 (55.8) 339 (57.0)
Marital status (%)
    Married 1,082 (66.0) 330 (67.1)
    Single 65 (4.0) 20 (4.1)
    Widowed/divorced 492 (30.0) 142 (28.9)
IMD 2004 score (median, IQR) 1,026 15.6 (9.6–25.5) 594 10.2 (6.3–16.9)
BMI (mean, sd) 1,597 29.7 (5.4) 595 30.7 (5.5)
EQ-5D-3L 5th question (%)
    Anxiety/depression 643 (39.3) 173 (32.3)
    No 993 (60.7) 362 (67.7)
OKS baseline (units, mean, sd) 1,649 18.3 (7.5) 542 19.4 (7.7)
ASA grade (%)
    Fit and healthy 277 (17.5) 49 (9.4)
    Asymptomatic no restriction 991 (62.8) 381 (73.4)
    Symptomatic minimal/severe restriction 311 (19.7) 89 (17.2)
Disease type (%)
    Osteoarthritis 1,561 (95.3) 465 (94.5)
    Rheumatoid arthritis 77 (4.7) 27 (5.5)
Disease side (%)
    One knee 432 (26.4) 83 (20.3)
    Both knees 642 (39.2) 192 (46.8)
    General 564 (34.4) 135 (32.9)
Previous knee arthroscopy (%)
    No 1,420 (86.7) 472 (89.4)
    Yes 218 (13.3) 56 (10.6)
Other condition affecting mobility (%)
    No 1,411 (86.3) 56 (10.3)
    Yes 224 (13.7) 487 (89.7)
Fixed flexion deformity (%)
    No 690 (42.6) 151 (37.3)
    Yes 930 (57.4) 254 (62.7)
Pre-operative ACL (%)
    Intact (<5 mm) 1,054 (65.4) 282 (75.2)
    Damaged (≥5 mm), absent 558 (34.6) 93 (24.8)
Table 1. Patient characteristics in the development and the validation cohorts. KAT, knee arthroplasty trial; 
COASt, clinical outcomes in arthroplasty study; OKS, Oxford knee score; IQR, interquartile range; sd, standard 
deviation; BMI, body mass index; EQ-5D-3L, 3-level version of the EuroQol five dimensions questionnaire; 
IMD, index of multiple deprivation; ASA, physical status classification system of the American society of 
anaesthesiologists; ACL, anterior cruciate ligament.
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as BMI is known to be associated with limited physical performance31, the judgment of obese patients on their 
health status may be based on functional mobility. Although the relationship was statistically significant, the effect 
size was not a clinically important, meaning that BMI should not be a barrier to surgery.
In relation to the clinical variables, we found that patients with worse pre-operative physical status (ASA grade 
3–4), compared to fit and healthy, pre-operative disability and previous knee arthroscopy were associated with 
worse outcome, and these results were consistent with other studies3,18.
We found that patients with a fixed flexion deformity, or an absent pre-operative ACL, achieved better out-
comes one year after TKR, even after adjustment for pre-operative OKS and this finding has been previously 
reported in other study using KAT data32. Patients with a pre-operative fixed flexion deformity were more likely 
to present absent/damaged pre-operative ACL in this study. Also, these patients presented with similar or even 
better pre-operative characteristics compared with those without fixed flexion deformity and intact pre-operative 
(data not shown).
This study has several strengths: (1) Large sample size. A total of 1,649 patients were included in the develop 
analysis (2) the use of a wide range of predictor variables, including socio-demographic and almost unique data 
on clinical factors, (3) the use of multiple imputation and bootstrapping as an internal validation technique33, to 
ensure significant predictors are and not anomalous to this dataset, (4) in addition good reproducibility of the 
model has been confirmed by external validation34,35, and (5) collating these risk factors together to develop a 
clinical prediction model that may be informative for decision making.
There are some potential limitations to this study. First, although calibration of the prediction model was good 
for predicting attained post-operative OKS, and change (improvement in OKS), it does not currently predict 
dichotomous “good” or “poor” outcome (e.g. a change in score of less than 5 points”). This model could be tested 
against such definitions once they have been agreed.
Intercept and Predictors (reference 
category)
Overall (n = 1,649)
% Retained in final model Coefficient (95% CI) P-value
Intercept 32.9
Age at operation (<60 years)
    60–69 years 100% (forced) 0.8 (−1.5 to 3.1) 0.477
    70 to 79 years 100% (forced) 1.4 (−0.9 to 3.6) 0.238
    80 years or more 100% (forced) −2.5 (−5.5 to 0.4) 0.088
Gender (Female)
    Male 100% (forced) −4.8 (−8.0 to −1.6) 0.003
Age x gender (<60 years x female)
    60–69 years x male 90% 4.8 (1.4 to 8.3) 0.006
    70 to 79 years x male 84% 4.3 (0.8 to 7.7) 0.015
    80 years or more x male 100% 8.1 (4.0 to 12.3) <0.001
IMD 2004 score (10 units) 97% −0.6 (−1.0 to −0.2) 0.008
BMI, kg/m2 (10 units) 96% −1.5 (−2.4 to −0.6) 0.001
EQ-5D-3L 5th question (No)
    Anxiety/depression 98% −1.6 (−2.5 to −0.6) 0.001
OKS baseline 100% 0.4 (0.3 to 0.4) <0.001
ASA grade (Fit and healthy)
    Asymptomatic no restriction 55% ─ ─
    Symptomatic minimal/severe restriction 97% −2.0 (−3.2 to −0.8) 0.001
Previous knee arthroscopy (No)
    Yes 82% −1.6 (−3.0 to −0.2) 0.025
Other condition affecting mobility (No)
   Yes 100% −3.3 (−4.7 to −2.0) <0.001
Fixed flexion deformity (No)
    Yes 100% 1.7 (0.8 to 2.6) <0.001
Pre-operative ACL (Intact)
    Damaged/absent 81% 1.0 (0.1 to 2.0) 0.029
R2 19.3%
Optimism 1.6
Bias-corrected R2 17.6%
Table 2. General linear model identifying predictors of knee pain and function 12-month after total knee 
replacement in the development dataset. OKS, Oxford knee score; IMD, index of multiple deprivation; BMI, 
body mass index; ASA grade, physical status scoring according to the American society of anaesthesiologists; 
ACL, anterior cruciate ligament; EQ-5D-3L, 3-level version of the EuroQol five dimensions questionnaire; CI, 
confidence interval. Variables included in the final regression model are those that are retained in at least 70% of 
the 200 bootstrap backward selection regression models.
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Second, potential predictive factors, principally radiographic variables (e.g. Kellgren and Lawrence (KL) grade 
of OA), were not available in this study. In addition, lifestyle measures such as smoking, alcohol consumption 
and exercise were not available in the development dataset, and hence we did not consider them in this study. 
We therefore used BMI and area deprivation, which have been shown to correlate well with behavioural risk fac-
tors36. Similarly, race was not collected in the KAT study, and hence this variable was not included in the analysis. 
Since patients included in the COASt study were predominantly white (over 95%), and both studies had similar 
patient’s characteristics, the results of this study may not be generalizable to other racial groups. Future research 
should focus on predictors of outcome after TKR in different racial groups.
Third, nonresponse bias from this study limits the generalizability of study findings. Nonresponses were more 
likely to have worse outcome and reported anxiety and depression, thus this implies that the true effects of these 
predictors may be underestimated in this study. Importantly, external validation has confirmed the calibration 
and discrimination ability of the model.
Finally, R2 values were relatively low, predictive factors explained 17.5% and 21% of the variability in outcome, 
suggesting that the nature of the health status in TKR patients is multifactorial. However, since strong statistically 
significant predictors were found, we can still draw important conclusions about how changes in the predictor 
values are associated with changes in the outcome. Those values are consistent with other studies attempting to 
explain the variability in outcome of TKR13,22,23 and also with other well-known prediction tools such as QRISK 
and Framingham score that explain around 30% of the variability in outcome37.
We have developed and for the first time externally validated a clinical prediction model for outcome 
12-month after TKR. Clinicians could use information on the level of patient outcome improvement, when coun-
selling patients about the prognostic of TKR, allowing to the patients to be involved in the decision whether to 
undergo surgery. External validation has confirmed its performance and validity and it can be already used in 
clinical practice.
Patients and Methods
Data sources. Development dataset. This study was carried out using data from the KAT trial20,21: a prag-
matic, partial-factorial, unblinded randomised controlled trial (International Standard Randomized Trial No. 
ISRCTN45837371). Patients were recruited from July 1999 to January 2003 through a random sample, stratified 
by surgeon according to age group, gender and site of disease. The KAT study contains information on patients 
receiving primary TKR across 34 centres in the UK.
Validation dataset. COASt, is a prospective, longitudinal cohort including patients waiting for hip and knee 
operations across two UK tertiary hospitals: Southampton University Hospital, and Nuffield Orthopaedic Centre 
(NOC) in Oxford. Southampton University Hospital provides services to some 1.3 million people, whereas NOC 
serves a population of around 655,000 people. Patients were recruited between 2010 and 2014.
Figure 1. Calibration plot with R2. (a) Calibration plot of the imputed development dataset (n = 1,649). (b) 
Calibration plot of the external dataset also imputed (n = 595). Internal and external samples used for validation 
were divided in 10 deciles, according to their predicted risk. For each decile, the mean predicted risk and 
the mean observed cases are shown on the X and Y axes, respectively. Bars indicate 95% Poisson confidence 
intervals.
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Participants. Development dataset. Patients were eligible for inclusion in KAT if a decision had been made 
for them to undergo primary TKR21. A participant was not eligible if the surgeon considered a particular type of 
operation to be clearly indicated (metal-backed tibial component, patellar resurfacing and/or a mobile bearing). 
4,070 potentially eligible patients were found and 2,374 (58%) provided their consent and were randomised. Of 
those, 22 were later discarded because were randomised in error, which left 2,352 participants in the trial. For the 
purpose of the present study, 1,649 individuals (41%) with available data about OKS at baseline and year 1 were 
selected.
Validation dataset. Patients included had osteoarthritis (OA) or rheumatoid arthritis (RA). They were over 18 
years and were competent and willing to consent to undergo primary TKR. 1,674 patients who underwent knee 
replacement were initially accepted by COASt study. Fifty-seven patients (3%) were excluded because of (a) dupli-
cation, (b) ineligibility, (c) withdrawn, (d) limited consent, (e) preoperatively assessed knee was different than the 
actual operated knee, or (f) any data provided. Patients undergoing patella-femoral resurfacing (n = 16, 1%), TKR 
revision (n = 112, 7%) and unicompartmental knee replacement (n = 643, 38%) were also excluded. Finally, 595 
answering about OKS at year 1 (36%) were used for the external validation.
Outcome. The outcome was the patient’s pain and functional status as measured by the OKS at 12-month 
after primary TKR. OKS is a validated patient-administered questionnaire which consists of 12 questions relating 
to knee pain and physical function limitations during the past 4 weeks38. Each question is on a Likert scale taking 
values from 0 to 4, with 4 being the best outcome. A total score was created ranging from 0 (severe symptoms 
and dysfunction) to 48 (no problem on any item)7. OKS questionnaires were also completed by participants 
pre-operatively. Patients were required to answer OKS questionnaires thinking of their operated knee in devel-
opment and validation studies.
Predictor variables. The pre-operative patient characteristics included were age, gender, marital status, 
socioeconomic deprivation measured by Index of Multiple Deprivation 2004 (IMD)39, BMI and mental health 
(Table 3). As the association of age on outcome was non-linear, we considered age according to the categories 
used in the randomization process: less than 60 years; 60 to 69 years; 70–79 years and 80 years or older. The IMD 
2004, based on patients’ residential postcodes, combines weighted scores for each postcode in seven depriva-
tion domains, where a high score indicates increased deprivation. BMI was calculated at baseline as the ratio 
of the weight to the square of height in meters (kg/m2). Values of IMD 2004 and BMI were collapsed each 10 
units. Mental health was assessed using the anxiety/depression item of the European Quality of life-five domain 
(EQ-5D-3L) questionnaire40.
The following variables were considered as potential clinical risk factors: (a) physical status such as is classified 
by the American Society of Anesthesiologists (ASA) grade. This grading system is a standard assessment of the 
patient’s general physical health prior to surgery41. It is composed by four categories (1, fit and healthy; 2, mild 
disease; 3, incapacitating disease; and 4, life-threatening disease) but for this study the last two categories were 
collapsed, (b) disease type (OA, RA), (c) disease side (left, right)42, (d) previous knee arthroscopy (it happened in 
any time for the development dataset while for the validation dataset it only referred to the 12 previous months 
before TKR), (e) presence of other conditions affecting mobility, (f) pre-operative fixed flexion deformity and (g) 
pre-operative status of anterior cruciate ligaments (ACL) (Table 3).
Clinical pre-operative factors refer to the operated knee in the development and the validation datasets.
Statistics. All analyses were conducted using the Stata version 13.1 statistical software (StataCorp, College 
Station, Texas). To determine selection (response) bias, an analysis was conducted to compare patient character-
istics in responders and non-responders to both pre-operative and 12 months post-operative OKS questionnaires 
in the development dataset.
General linear models were used to identify predictors on post-operative OKS. Linearity of continuous varia-
bles with the outcome was assessed using fractional polynomials and collinearity between variables was assessed 
by the variance inflation factor (VIF). Because the variance of the residuals is non-constant (evidence of hetero-
scedasticity), robust standard errors were used with the sandwich variance estimator43. Interactions between age 
and sex with all other factors were tested. To get the fit of the final model with the smallest number of variables 
and the best predictive validity, we followed these steps44–46: Step 1: multiple imputed dataset using chained equa-
tions was generated to investigate the impact of missing data47. Forty imputed datasets were generated using all 
potential factors (including the outcome) and estimated parameters were combined using Rubin’s rules; Step 2: 
bootstrap linear regression model method with the sandwich variance estimator was used. We drew 200 bootstrap 
samples with replacement from the combined 40 imputed datasets. Within each bootstrap sample, automatic 
backward selection was applied using a significance level equal to 0.157 (except age and gender were force-entered 
into all models)48; Step 3: variables which appeared at least 70% of the time were retained in the final regression 
model.
Internal validation. To check the internal validity of the model, 200 bootstrap samples with replacement com-
bined with multiple imputations was once again used to assess bias-corrected estimates of predictive ability43. 
Predictive ability was assessed by examining measures of discrimination (R2 statistic) and calibration48,49. Samples 
were divided in ten deciles for calibration according to their predicted risk. For each decile, means of predicted 
and observed OKS were obtained. For each observed mean was also calculated its 95% Poisson confidence 
interval.
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External validation. For the external validation, the missing values of the predictors selected in the prediction 
model were also imputed using the same procedure describe above. We applied the pooled coefficients of the 
model developed in KAT with the forty imputed datasets of COASt, and we then calculate discrimination and 
calibration. Discrimination was calculated by the pooled R2 statistics using Fisher’s r to z transformation50.
Sensitivity analysis. Finally, to evaluate whether there were differences in post-operative OKS for patients with 
RA versus OA, we conducted an analysis excluding patients with RA; because no substantial model differences 
were observed, these supporting analysis are not shown.
Ethics. For the KAT trial ethical approval was obtained from by the Multi Centre Research Ethics Committee 
for Scotland in November 1998 (research protocol MREC/98/0/100) and was approved by the Local Research 
Ethics Committees in each study centre recruiting trial participants.
COASt has been approved by the Oxford REC A (Ethics Reference: 10/H0604/91). The sponsoring organisa-
tion of the study is the University Hospitals Southampton NHS Foundation Trust (UHS).
Both cohorts confirm to national guidelines and individual ethics and data protection requirements. Data 
were collected within the two cohorts in an anonymised format as confirmed by the study participants in their 
written informed consent and as directed by the ICH-GCP guidelines and appropriate local and International 
legislation. It was not be possible to re-identify the donors. Datasets were stored at the University of Oxford in 
a secure database. The data storage, management and handling were protected in accordance with European 
Commission Directive 95/46/EC and appropriate national regulations.
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